Bogart Wealth LLC’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$510K Sell
10,694
-20
-0.2% -$927 0.02% 187
2026
Q1
$469K Buy
10,714
+253
+2% +$11.5K 0.02% 179
2025
Q4
$464K Buy
10,461
+237
+2% +$10.2K 0.02% 174
2025
Q3
$432K Buy
10,224
+12
+0.1% +$484 0.02% 175
2025
Q2
$374K Hold
10,212
– – 0.02% 182
2025
Q1
$389K Hold
10,212
– – 0.02% 172
2024
Q4
$387K Hold
10,212
– – 0.02% 174
2024
Q3
$416K Hold
10,212
– – 0.02% 166
2024
Q2
$350K Hold
10,212
– – 0.02% 171
2024
Q1
$323K Hold
10,212
– – 0.02% 169
2023
Q4
$313K Hold
10,212
– – 0.02% 174
2023
Q3
$339K Hold
10,212
– – 0.02% 159
2023
Q2
$313K Hold
10,212
– – 0.02% 172
2023
Q1
$280K Sell
10,212
-500
-5% -$13.9K 0.02% 164
2022
Q4
$299K Buy
10,712
+4,695
+78% +$142K 0.02% 161
2022
Q3
$177K Buy
6,017
+500
+9% +$15.7K 0.01% 178
2022
Q2
$156K Hold
5,517
– – 0.01% 173
2022
Q1
$172K Buy
5,517
+1,751
+46% +$51.6K 0.01% 166
2021
Q4
$111K Buy
3,766
+2,323
+161% +$67.8K 0.01% 189
2021
Q3
$43K Buy
+1,443
New +$49.6K ﹤0.01% 260

Other funds holding OHI

Bogart Wealth LLC's OHI Position: Q2 2026 in Review

Bogart Wealth LLC reduced its Omega Healthcare (OHI) stake by 0.19% in Q2 2026, selling an estimated $927 and leaving 10,694 shares worth $510K. The position accounts for 0.02% of the portfolio, ranked #187.

Bogart Wealth LLC first reported a position in OHI in Q3 2021 and has held it in 20 quarters since. 764 funds tracked by Wall St. Rank hold OHI as of Q2 2026.

  • Bogart Wealth LLC held 10,694 shares of Omega Healthcare worth $510K as of Q2 2026.
  • Bogart Wealth LLC sold 20 Omega Healthcare shares in Q2 2026, an estimated $927.
  • Omega Healthcare made up 0.02% of Bogart Wealth LLC's portfolio in Q2 2026, its #187 holding.
  • Bogart Wealth LLC first reported a position in Omega Healthcare in Q3 2021 and has held it in 20 quarters since.
  • 764 funds tracked by Wall St. Rank held Omega Healthcare as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.